Skip to content
2000
Volume 8, Issue 2
  • ISSN: 1874-4710
  • E-ISSN: 1874-4729

Abstract

Lutetium-177 (177Lu) is a late entrant into the nuclear medicine therapy arena but is expected to become one of the most widely used therapeutic radionuclides. This paper analyses the reason for the increasing preference of 177Lu as a therapeutic radionuclide. While the radionuclidic properties favor its use for several therapeutic applications, the potential for large scale production of 177Lu is also an important aspect for its acceptability as a therapeutic radionuclide. This introductory discussion also summarizes some developing clinical uses and suggested future directions for applications of 177Lu.

Loading

Article metrics loading...

/content/journals/crp/10.2174/1874471008666150312155959
2015-08-01
2025-05-28
Loading full text...

Full text loading...

/content/journals/crp/10.2174/1874471008666150312155959
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test